The popularity of Viagra initially fueled a period of growth for pharma, however recent changes present a murky scenario for those considering a stake. Generic alternatives are reducing profits, and continued patent https://owainlqwg387796.blogginaway.com/41938233/the-blue-pill-and-big-pharma-a-risky-play